Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021

Despite belonging to a relatively new class of pharmaceuticals, biological drugs have been used since the 1980s, when they brought about a breakthrough in the treatment of chronic diseases, especially cancer. They conquered a large space in the pipeline of the pharmaceutical industry and boosted the...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Alexander C. Martins, Mariana Y. Oshiro, Fernando Albericio, Beatriz G. de la Torre, Gustavo José V. Pereira, Rodrigo V. Gonzaga
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Subjects:	Food and Drug Administration FDA approvals monoclonal antibody antibody–drug conjugate first global approval biological drugs
Online Access:	https://www.mdpi.com/2227-9059/10/9/2325